2型心肌梗死18个月死亡预测模型的开发与验证
该前瞻性观察研究纳入2017年1月至2018年12月间712例连续接受冠状动脉造影(<24小时)的心肌梗死患者,按第三版通用定义诊断2型心肌梗死(T2MI)174例(24.4%),中位年龄69岁,52%为女性,18个月死亡率为20.1%。采用贝叶斯方法和逻辑回归构建预后模型,经bootstrap验证,乐观校正c统计量为0.822,校正斜率为0.893。GRACE和TARRACO评分的c统计量分别为0.748(95%CI 0.652-0.843)和0.741(95%CI 0.669-0.805),模型区分度均优于两者(p=0.043和0.037)。作者认为该模型可准确预测T2MI患者死亡风险,但临床应用前需进一步外部验证列线图。
要点
- 在712例接受冠状动脉造影的MI患者中,T2MI占174例(24.4%),18个月死亡率为20.1%。
- 既往心梗、ST段抬高、入院血红蛋白水平、Charlson合并症指数与18个月死亡率独立相关。
- 预测模型乐观校正c统计量为0.822,校正斜率为0.893,区分度和校准度良好。
- GRACE评分c统计量0.748(95%CI 0.652-0.843),TARRACO评分0.741(95%CI 0.669-0.805),模型均优于两者(p=0.043和0.037)。
- 作者结论:T2MI患者死亡风险可用常见临床特征和实验室检查准确预测;临床应用前需进一步外部验证列线图。
适用人群与场景
- 2017年1月至2018年12月间连续纳入的712例诊断为心肌梗死并在24小时内接受冠状动脉造影的患者。
- 其中按第三版通用定义诊断为2型心肌梗死的174例(24.4%)患者,中位年龄69岁,52%为女性。
诊断标准与关键阈值
- 2型心肌梗死诊断依据第三版通用定义。
研究设计与关键结果
- 研究类型:前瞻性观察研究,纳入712例连续接受冠状动脉造影(<24小时)的心肌梗死患者,其中T2MI 174例(24.4%)。
- 人群特征:中位年龄69岁,52%为女性;18个月死亡率为20.1%。
- 模型构建:采用贝叶斯方法和逻辑回归分析识别死亡预测因子,并通过bootstrap验证。
- 独立预测因子:既往心梗、ST段抬高、入院血红蛋白水平、Charlson合并症指数与18个月死亡率独立相关。
- 模型性能:乐观校正c统计量=0.822,校正斜率=0.893。
- GRACE评分c统计量=0.748(95%CI 0.652-0.843),TARRACO评分c统计量=0.741(95%CI 0.669-0.805),模型区分度均优于两者(p=0.043和p=0.037,Delong检验)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:作者指出临床应用前需进一步外部验证列线图。
对床旁实践的改变
- 作者认为,T2MI患者的死亡风险可通过常见临床特征和实验室检查准确预测。
- 作者指出,在临床实施前需进一步研究对列线图进行外部验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite the poor prognosis in patients with type 2 myocardial infarction (MI), no prospective data on risk stratification exists. The aim of this study was to develop and validate a model for prediction of 18-month mortality of among patients with type 2 MI (T2MI) and compare its performance with GRACE and TARRACO scores.
METHODS: The prospective observational study included 712 consecutive patients diagnosed with MI undergoing coronary angiography <24 h between January 2017 and December 2018. Diagnosis of T2MI was adjusted according to Third universal definition. A prognostic model was developed by using Bayesian approach and logistic regression analysis with identifying predictors for mortality. The model was validated by bootstrap validation. Comparison performance between scores using Delong test.
RESULTS: T2MI was identified in 174 (24.4%) patients. The median age of patients was 69 years, 52% were female. The mortality rate was 20.1% at 18 months. Prior MI, presence of ST elevation, hemoglobin level at admission, Charlson comorbidity index and were independently associated with 18-month mortality. The model to predict 18-month mortality showed excellent discrimination (optimism corrected c-statistic = 0.822) and calibration (corrected slope = 0.893). GRACE and TARRACO scores had moderate discrimination [c-statistic = 0.748 (95% CI 0.652-0.843) and 0.741, 95% CI 0.669-0.805), respectively] and inferior compared with model (p = 0.043 and 0.037, respectively).
CONCLUSIONS: The risk of mortality among T2MI patients could be accurately predicted by using common clinical characteristics and laboratory tests. Further studies are required with external validation of nomogram prior to clinical implementation.
参考来源
- Hoang TH, Maiskov VV, Merai IA, et al. Development and validation of a model for predicting 18-month mortality in type 2 myocardial infarction. Am J Emerg Med. 2021. PMID: 33984591. doi:10.1016/j.ajem.2021.04.060
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。